SCHEMBL19360425

SCHEMBL19360425

COC(=O)c1ccc2c(c1)cc(Cc1ccccc1C(F)(F)F)n2C1CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.52
KIF11 P52732 5/20 0.47
RBP4 P02753 1/20 0.43
IDH1 O75874 3/20 0.42
EPHX2 P34913 3/20 0.41
NOTUM Q6P988 1/20 0.40
CYP2C9 P11712 2/20 0.39
SLC6A4 P31645 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TAOK1 Q7L7X3 1/20 0.38
TAOK3 Q9H2K8 1/20 0.38
PPARG P37231 1/20 0.38
ABL1 P00519 1/20 0.38
SRC P12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30076050 1.00 RORC (0.52) RORCKIF11RBP4IDH1EPHX2
SCHEMBL19360582 0.89 RORC (0.54) RORCKIF11RBP4IDH1EPHX2
SCHEMBL19360312 0.89 RORC (0.66) RORCKIF11RBP4IDH1NOTUM
SCHEMBL19360436 0.88 RORC (0.51) RORCKIF11RBP4IDH1EPHX2
SCHEMBL19360539 0.83 RORC (0.46) RORCIDH1SLC6A4HRH3ALDH1A1
SCHEMBL19360399 0.83 IDH1 (0.53) RORCIDH1ALDH1A1TDP1
SCHEMBL19360520 0.82 KIF11 (0.51) RORCKIF11RBP4EPHX2NOTUM
SCHEMBL19360580 0.82 RORC (0.63) RORCKIF11NOTUMCYP2C9
SCHEMBL30076092 0.81 RORC (0.45) RORCKIF11EPHX2ALDH1A1PPARG
SCHEMBL28197903 0.80 IDH1 (0.53) RORCIDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109963836-B Deuterium atom substituted indole carboxamide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-11-22 CN disclosed
CN-107531679-B Aromatic amide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2021-07-02 CN disclosed
US-20200277278-A1 Deuterium Atom-Substituted Indole Formamide Derivative, Preparation Method Therefor, and Medical Applications Thereof JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2020-09-03 US disclosed
EP-3683206-A1 DEUTERIUM ATOM-SUBSTITUTED INDOLE FORMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL APPLICATIONS THEREOF Jiangsu Hengrui Medicine Co., Ltd. (CN) 2020-07-22 EP disclosed
CN-109963836-A Indole carboxamides analog derivative, preparation method and its application in medicine that D-atom replaces 江苏恒瑞医药股份有限公司 2019-07-02 CN disclosed
CN-107531679-A Aromatic amides analog derivative, its preparation method and its application in medicine 江苏恒瑞医药股份有限公司 2018-01-02 CN disclosed
WO-2017157332-A1 AROMATIC AMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATIONS THEREOF 江苏恒瑞医药股份有限公司 2017-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200277278-A1 Deuterium Atom-Substituted Indole Formamide Derivative, Preparation Method Therefor, and Medical Applications Thereof RORA, RORB, RORC RORC 3/4885KIF11 562/4885RBP4 3145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.